Similar articles

• Partitioning phenomena in dosage form and biopharmaceutical design. I. Prognostic significance of partition coefficients.

  [No authors listed] [No authors listed] Am J Hosp Pharm. 1971 Oct;28(10):796-9. Am J Hosp Pharm. 1971. PMID: 5125175 No abstract available.
• Partitioning phenomena in dosage form and biopharmaceutical design. II. Some partitioning considerations in dosage form design.

  Schumacher GE. Schumacher GE. Am J Hosp Pharm. 1971 Dec;28(12):985-8. Am J Hosp Pharm. 1971. PMID: 5135196 No abstract available.
• Bioavailability of drugs (first of two parts).

  Koch-Weser J. Koch-Weser J. N Engl J Med. 1974 Aug 1;291(5):233-7. doi: 10.1056/NEJM197408012910505. N Engl J Med. 1974. PMID: 4600408 Review. No abstract available.
• [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].

  Levy G, Barr WH. Levy G, et al. Internist (Berl). 1973 Dec;14(12):661-7. Internist (Berl). 1973. PMID: 4593013 German. No abstract available.
• Human in vivo regional intestinal permeability: importance for pharmaceutical drug development.

  Lennernäs H. Lennernäs H. Mol Pharm. 2014 Jan 6;11(1):12-23. doi: 10.1021/mp4003392. Epub 2013 Nov 22. Mol Pharm. 2014. PMID: 24206063 Review.